Jushi Holdings Earnings Call Balances Progress and Pressure

Jushi Holdings Inc ((TSE:JUSH)) has held its Q4 earnings call. Read on for the main highlights of the call.

Jushi Holdings’ latest earnings call struck a cautiously optimistic tone as management emphasized operational gains and margin expansion against a backdrop of modest revenue growth and heavy debt costs. Executives highlighted improved yields, better product quality and a non‑dilutive refinancing, while acknowledging persistent pricing pressure, larger net losses and reliance on tax credits to bolster adjusted EBITDA.

Revenue Growth (Q4 and Full Year)

Jushi reported Q4 2025 revenue of $68.3 million, up roughly 4% from $65.9 million a year earlier, with full‑year sales reaching $262.9 million for a little over 2% growth. Management framed this as evidence of stabilization across its retail footprint, supported by contributions from newly opened stores in key markets.

Improved Gross Profit and Q4 Margin Expansion

Fourth‑quarter gross profit rose to $28.6 million, or 41.9% of revenue, versus $25.4 million and a 38.6% margin in Q4 2024. The company credited higher production volumes, better product quality and operational gains at its grower‑processor facilities for the improved profitability in the quarter.

Material Adjusted EBITDA Improvement

Adjusted EBITDA for Q4 climbed to $13.9 million, a 20.4% margin, compared with $8.0 million and a 12.2% margin in the prior‑year period. For 2025, adjusted EBITDA increased to $50.3 million from $46.2 million, with the full‑year margin expanding to 19.1% from 17.9%.

Operational Turnaround at Grower-Processor Facilities

Management emphasized a meaningful turnaround in cultivation, as average yield per square foot increased about 28% year over year in Q4 while maintaining potency in the mid‑ to upper‑20% THCa range. These improvements supported a more favorable product mix across both retail and wholesale channels, helping underpin margin gains.

Strategic Retail Growth and Branded Mix

The company expanded its retail footprint from 38 to 42 stores, an increase of roughly 11% year over year, while keeping headcount growth to about 4%, showcasing scaling efficiency. Jushi‑branded products accounted for around 58% of retail revenue in Q4, up from 55% a year earlier, supporting brand strength and vertical integration benefits.

Refinancing Strengthens Near-Term Liquidity

Jushi completed a $160 million first‑lien secured term loan due 2029 with a 12.5% coupon, using proceeds to repay a roughly $46 million term loan and about $86 million of second‑lien notes. The transaction added approximately $13 million of incremental liquidity, extended maturities and avoided equity dilution, with the CEO increasing his personal capital participation.

Regulatory Progress – Virginia Adult Use

Executives highlighted that Virginia’s adult‑use legislation has been reconciled and sent to the governor, mapping a path to legal sales in 2027. Under the current timeline, applications are expected by September 1, 2026, licenses by December 1, 2026 and retail adult‑use sales starting January 1, 2027, with Jushi planning to leverage existing infrastructure with limited new capital.

Selective CapEx Discipline and 2026 Guidance

Capital expenditures in 2025 totaled $16.1 million, split between $4.8 million of maintenance and $11.3 million of growth spending. For 2026, the company guided to a lower $9–13 million CapEx budget, with $4–5 million for maintenance and $5–8 million for growth, underscoring disciplined allocation tied to regulatory visibility.

Modest Top-Line Growth Overall

Despite positive commentary on operations, the company’s top line advanced only modestly, with full‑year revenue up just over 2% and Q4 revenue up about 4% compared with 2024. Management acknowledged that competitive, price‑constrained markets are limiting headline growth even as internal efficiencies improve.

Full-Year Gross Margin Compression

For 2025 as a whole, gross profit slipped to $114.0 million, or 43.4% of revenue, from $118.3 million and a 45.9% margin the prior year. The decline reflects increased promotional activity and sustained pricing pressure across several markets, partially offsetting operational gains in cultivation.

Net Loss and High Interest Expense

The company’s Q4 net loss widened to $15.6 million from $12.5 million a year earlier, with interest expense in the quarter reaching $10.4 million. Jushi ended the year with about $193.1 million of debt and the new 12.5% term loan underscores that its funding costs remain elevated despite improved liquidity.

Adjusted EBITDA Benefited from One-Time Credits

Management noted that adjusted EBITDA results were boosted by roughly $3 million of employee retention credits in Q4 and around $10.6 million recognized for the full year. These non‑recurring credits partially inflated year‑over‑year operating comparisons, tempering the apparent strength of the EBITDA improvement.

Liquidity and Cash Levels

At December 31, 2025, Jushi held about $26.6 million in cash, cash equivalents and restricted cash, providing a modest cushion alongside the new term loan. However, the financing includes a covenant requiring the company to maintain a minimum cash balance, which limits flexibility to deploy cash aggressively.

Market Headwinds and Promotional Pressure

Management described ongoing pricing pressure and competitive dynamics across multiple markets, which are forcing deeper promotional activity, especially around holiday periods. These discounting strategies help defend market share but weigh on margins, underscoring the challenging retail backdrop.

Wholesale and Market-Specific Weaknesses

Wholesale revenue posted only modest gains, rising to $7.9 million from $7.7 million sequentially, with particular weakness in Virginia where wholesale sales fell by roughly $1.2 million as partners prioritized their own vertical products. The company also terminated a planned Mt. Laurel, N.J. location, reflecting selective retrenchment in certain markets.

Potential Large Conversion Fee and Regulatory Uncertainty

Under current Virginia legislation, converted medical licenses would owe a $10 million conversion fee, potentially payable under a structured plan, representing a significant future cash outlay. Management also flagged broader regulatory uncertainty around federal rescheduling, hemp rule implementation and capital market reforms that could materially impact the industry.

Forward-Looking Guidance and Outlook

Looking ahead, Jushi expects 2026 CapEx to remain contained at $9–13 million, with most major construction, including larger Virginia build‑outs, deferred to 2027 and likely funded via mortgage or facility‑level debt. Management anticipates Virginia adult‑use sales beginning in 2027 and pointed to prior transitions, such as New Jersey’s roughly 3.2x uplift, as a rough benchmark for the potential impact on that market.

Jushi’s earnings call painted a picture of a company making tangible operational strides and shoring up its balance sheet, yet still grappling with thin growth, high interest costs and intense market competition. For investors, the story hinges on whether disciplined spending, improving margins and the eventual Virginia adult‑use launch can outweigh current headwinds and convert cautious optimism into durable earnings growth.